样式: 排序: IF: - GO 导出 标记为已读
-
Interleukin-18 as a crucial cytokine in chronic arthritic systemic juvenile idiopathic arthritis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-18 Takako Miyamae, Yumi Tani, Eisuke Inoue, Kawabe Tomohiro, Masayoshi Harigai
CONFLICT OF INTEREST STATEMENT TM has received speaker’s fee from AbbVie Japan GK, Ayumi Pharmaceutical Co., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Novartis Japan, Pfizer Japan Inc. TM has received royalties from Chugai Pharmaceutical Co., Ltd. EI has received lecture fees or consulting fees from Bristol Myers Squibb Co., Ltd., Pfizer Japan Inc., and Nippontect systems Co. Ltd. MH has received
-
Case report: Dysgeusia in a senile male systemic lupus erythematosus patient with serious cytomegalovirus infection Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 I‐Ting Tsai, Hung‐Hsin Lin, Chia‐Hua Lin, Feng‐Cheng Liu, Hsiang‐Cheng Chen, Fu‐Chiang Yeh
-
Case report: Rare neurological symptoms of sulfasalazine‐induced hypersensitivity syndrome Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 Yiqi Shen, Sijie Li, Mengting Qian, Xiaoru Xia
-
Targeting osteoblast‐specific transcription factor: A common approach for ankylosing spondylitis and the tumor microenvironment Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 Po‐Hung Chen, Su‐Boon Yong, Wan‐Ting Liao, Meng‐Yu Wu, Chia‐Jung Li, I‐Ming Jou
-
Social activity, physical exercise, and health‐related quality of life among people with osteoarthritis in Canada Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 Pin‐Chia Huang, Kevin Sheng‐Kai Ma
-
Case report: Pulmonary endarterectomy in Takayasu arteritis patient with group IV pulmonary hypertension: A rare clinical scenario Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 Erdinc Unaldi, Busra Firlatan, Selin Ardali Duzgun, Suleyman Serdar Koca, Bedrettin Yildizeli, Ali Akdogan
-
The impact of glucocorticoid use on the outcomes of rheumatoid arthritis in a multicenter ultrasound cohort study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-16 Fumiaki Nonaka, Shoichi Fukui, Tohru Michitsuji, Yushiro Endo, Ayako Nishino, Toshimasa Shimizu, Masataka Umeda, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto, Tomoki Origuchi, Yukitaka Ueki, Nobutaka Eiraku, Takahisa Suzuki, Akitomo Okada, Naoki Matsuoka, Hirokazu Takaoka, Hiroaki Hamada, Tomomi Tsuru, Yojiro Arinobu, Toshihiko Hidaka, Keita Fujikawa, Tamami Yoshitama, Yoshifumi Tada, Hideo Ohtsubo
ObjectiveGlucocorticoids are effective in treating rheumatoid arthritis (RA) when used appropriately considering the balance of the risks and benefits, especially at low doses. We aimed to evaluate the response of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in patients having already been treated with glucocorticoids.MethodsWe reviewed RA patients treated with
-
The role of microbiota on rheumatoid arthritis onset Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-15 Milagros Faridy Juárez‐Chairez, María Stephanie Cid‐Gallegos, Cristian Jiménez‐Martínez, Luis Fernando Prieto‐Contreras, Juan José Bollain‐y‐Goytia de‐la‐Rosa
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation and pain, which can lead to the loss of normal joint function. Although the exact cause of the disease is not yet fully understood, both environmental factors and genetics may play a role in its development. Moreover, research suggests microbiota contributes to the onset and progression of RA. People with RA show higher
-
Editorial: Antenatal corticosteroids for pregnancy and risk of serious infection—Revisiting the role of antenatal corticosteroids Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-11 Hsien‐Hung Chiu, Chin‐Yuan Yii, Su‐Boon Yong
1 BACKGROUND ACS are routinely prescribed for expectant individuals at risk of preterm birth between 24 and 34 weeks to mitigate the chances of neonatal respiratory distress syndrome. Yet, as their usage expands, there is a pressing need to examine the treatment's long-term safety. Synthetic corticosteroids, such as betamethasone and dexamethasone, readily across the placenta, leading to significant
-
Successful treatment of PASS syndrome with IVIG and anti‐IL‐1 treatment: A case report Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-11 Gizem Kırmızıer, Elif Altunel Kılınç, Nurdan Oruçoğlu Yıldırım, Ümit Türsen
PASS syndrome is a rare autoinflammatory disease characterized by acne vulgaris, hidradenitis suppurativa, pyoderma gangrenosum, and ankylosing spondylitis. Unlike other autoinflammatory disorders such as PAPA and PASH syndrome, there is no documented gene mutation link. Although there are no established treatment guidelines due to the rarity of these diseases, systemic corticosteroids, biologics,
-
Not an arthritis, but a fibrotic band of the quadriceps muscle: A case report of unilateral restricted knee flexion in an adolescent Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-09 Aylin Sariyildiz, Ilke Coskun Benlidayi, Ferhat Can Piskin, Bugra Kundakci, Ceren Ornek, Meryem Andirin
-
Factors associated with acute anterior uveitis history in patients with axial spondyloarthritis: Results of a longitudinal study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-08 Haluk Cinakli, Elif Durak Ediboglu, Dilek Solmaz, Servet Akar
BackgroundsAcute anterior uveitis (AAU) is the most common extra‐musculoskeletal manifestation in axial spondyloarthritis (axSpA).ObjectivesThe aim of the study is to evaluate the factors associated with AAU attacks in patients with axSpA during a 36‐month follow‐up period.MethodsIn total, 469 patients with axSpA were included in this observational study. Demographic data, clinical characteristics
-
Unveiling the age‐related dynamics in Sjögren's syndrome: Insights from heart rate variability and autonomic function Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-08 Hong‐Chun Lin, Chien‐Ming Yen, Wei‐Sheng Chen, Chih‐Chien Hsu, Yen‐Ying Kung, Jin‐Huang Wu, Yu‐Ting Su, Kuo‐Feng Chen, Hsin‐Yuan Chen, Chien‐Min Lien, Ming‐Jen Wang, Ching‐Mao Chang
BackgroundSjögren's Syndrome (SS), mainly affecting women in their midlife, is characterized by persistent inflammation in glands producing tears and saliva, often leading to significant complications. This study investigates the differences in autonomic system functioning between individuals with SS and healthy controls.MethodsFrom April 2019 to December 2022, 329 diagnosed primary SS (pSS) patients
-
How effective is local corticosteroid injection in patients with carpal tunnel syndrome?—A Cochrane Review summary with commentary Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Muhammad Tawab Khalil, Farooq Azam Rathore
-
Class‐Rheum for AI: Reflections from a Filipino Rheumatologist and Health Informatics graduate student Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Lisa S. Traboco
-
Correspondence: Association of estrogen deficiency on bone loss‐impact of gut microbiota Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Kai‐Yen Chang, Chi‐Tung Lu, Pei‐Chi Chen, Chin‐Yuan Yii
-
Association of BTN3A1 gene polymorphisms with systemic lupus erythematosus in a Chinese Han population Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Wang‐Dong Xu, Chan Yang, Rong Li, Yang‐Yang Tang, Da‐Cheng Wang, An‐Fang Huang
-
Hydroxychloroquine had neutral effect on long‐term risk of malignancy in rheumatoid arthritis patients: A population‐based retrospective cohort study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Xiu‐Juan Hou, Renin Chang, Yu‐Hsun Wang, Tian‐Lun Kang, James Cheng‐Chung Wei
BackgroundThe cancer risk in rheumatoid arthritis (RA) patients has been discussed. Hydroxychloroquine (HCQ) may exert protective effects against malignancy. The study investigated the association between HCQ use and the risk of subsequent malignancy in RA patients.MethodsCatastrophic illness certificated RA patients were extracted from the National Health Insurance Research Database. The index date
-
Combination treatment with rituximab and belimumab in shrinking lung syndrome in systemic lupus erythematosus Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Adriana C. Esteves, Beatriz Mendes, Helena Assunção, Luís S. Inês
CONFLICT OF INTEREST STATEMENT The authors have declared no conflicts of interest.
-
Are bisphosphonates effective in treating osteoporosis in children and adults with cystic fibrosis?—A Cochrane review summary with commentary Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Fatma Merih Akpinar
http://rehabilitation.cochrane.org The aim of this commentary is to discuss the Cochrane Review “Bisphosphonates for osteoporosis in people with cystic fibrosis”1 by Jeffery et al.,*† published by Cochrane Cystic Fibrosis and Genetic Disorders Group. This Cochrane Corner is produced in agreement with International Journal of Rheumatic Diseases by Cochrane Rehabilitation with views of the review summary
-
Risk of uveitis in autoimmune diseases patients treated with hydroxychloroquine: A population‐based retrospective cohort study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Yi‐Chiao Bai, Wuu‐Tsun Perng, Jing‐Yang Huang, Pei‐Lun Liao, James Cheng‐Chung Wei
ObjectiveUveitis is a common manifestation of various autoimmune diseases and can lead to severe visual impairment. Hydroxychloroquine (HCQ) is an antimalarial drug that is also used to treat autoimmune diseases. The aim of this study was to investigate the association between HCQ use and the incidence of uveitis in patients with autoimmune diseases, as well as to identify potential risk factors for
-
Toward a holistic tophus assessment in gout clinical trials: What lies beyond tophus count and size? Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-07 Kanon Jatuworapruk
1 TOPHUS BURDEN IS A MAJOR OUTCOME DOMAIN IN GOUT STUDIES Tophus burden is a crucial outcome domain in gout, the most prevalent inflammatory joint disease in adults worldwide, characterized by the continuous deposition of monosodium urate (MSU) crystals.1 Individuals with gout typically experience recurrent episodes of arthritis (gout flares) during the earlier phase of the disease. Without proper
-
Case report: Management of Epstein–Barr virus positive and methotrexate‐associated B‐cell lymphoma Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-06 Qi‐An Wang, Tien‐Ming Chan
-
Mechanism of KDM5A‐mediated H3K4me3 modification in the osteogenic differentiation of mesenchymal stem cells in steroid‐induced osteonecrosis of the femoral head Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-06 Yi Yan, Hao Yan, Zhilong Qiu, Liang Long
ObjectivesSteroid‐induced osteonecrosis of the femoral head (SONFH) is characterized by impaired osteogenesis in bone marrow mesenchymal stem cells (BMSCs). This study investigates the role of lysine‐specific demethylase 5A (KDM5A) in SONFH to identify potential therapeutic targets.MethodsHuman BMSCs were isolated and characterized for cell surface markers and differentiation capacity. A SONFH cell
-
Integrated bioinformatics analysis reveals vital genes and immune infiltration for the co‐occurrence of Epstein–Barr virus‐related infectious mononucleosis and systemic lupus erythematosus Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-06 Yuchen Liu, Lifan Zhang
-
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome may present with extra‐articular and cutaneous manifestations Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-06 YuRu Zhang, ZiXiang Zheng, MengJiao Gu, YuanHao Wu, Chen Li
SAPHO syndrome is a rare autoinflammatory disease that manifests with articular and cutaneous symptoms. Although epidemiological data on SAPHO are limited, the annual incidence of the disease is estimated to be 1 in 10 000 in Caucasians and 0.00144 in 10 000 in Japanese.1 The precise pathogenesis of SAPHO syndrome remains elusive, but it is hypothesized to have a genetic basis, linked to underlying
-
Acquired generalized lipodystrophy in a juvenile dermatomyositis patient Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-06 Qiong Liu, Meng Pan, Hua Cao, Jie Zheng, Ye‐ping Ruan, Xiao‐qing Zhao
CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare.
-
When rheumatoid arthritis meets malignancy, what do we do? Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-05 Yixuan Li, Jing Wang, Ju Zhang, Huan Jiang, Aihui Liu, Zhenhua Ying
-
Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-05 Iku Shirasugi, Akira Onishi, Keisuke Nishimura, Wataru Yamamoto, Kosaku Murakami, Hideo Onizawa, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, Masaki Katayama, Ryota Hara, Koji Nagai, Yuri Hiramatsu, Motomu Hashimoto, Tadashi Okano, Toshihisa Maeda, Shinya Hayashi, Sho Sendo, Sadao Jinno, Yuzuru Yamamoto, Hirotaka Yamada, Yo Ueda, Jun Saegusa
AimTo investigate the association of large joint involvement (LJI) with disease activity and drug retention in patients with rheumatoid arthritis (RA) who started receiving a biological disease‐modifying antirheumatic drug or Janus kinase inhibitor.MethodsPatients with RA from a Japanese multicenter observational registry were enrolled. Our definition of large joints included the shoulder, elbow, hip
-
Cranial venous sinuses stenosis secondary to antineutrophil cytoplasmic antibody‐positive vasculitis‐associated hypertrophic cranial pachymeningitis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-05 Yujie Jiang, Hongwei Du
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.
-
Serum levels of CXCL5 are decreased and correlate with circulating platelet counts in systemic lupus erythematosus Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-05 Liang Zhang, Liling Zhao, Keqian Du, Juan Chen, Huihua Ding, Frank Petersen, Shuang Ye, Zhiming Lin, Xinhua Yu
ObjectiveTo identify disease‐specific serum chemokine profiles and potential anti‐inflammatory chemokines in three rheumatic diseases.MethodsThe discovery cohort included 18 patients with rheumatoid arthritis (RA), 20 patients with primary Sjögren's syndrome (pSS), 24 patients with systemic lupus erythematosus (SLE) and 28 healthy subjects. Findings from the discovery cohort were validated in two replication
-
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-03 Salvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, Tiziana De Rosa, Marco Matucci-Cerinic, Lorenzo Dagna, Leonardo Santo, Francesco Ciccia, Bruno Frediani, Marcello Govoni, Francesca Bobbio Pallavicini, Rosa Daniela Grembiale, Andrea Delle Sedie, Rita Mulè, Francesco Paolo Cantatore, Rosario Foti, Elisa Gremese, Paola Conigliaro, Fausto Salaffi, Ombretta Viapiana, Alberto Cauli, Roberto Giacomelli
Plain Language Summary A high proportion of patients may fail a first-line anti-TNF drug, necessitating the switch to another anti-TNF treatment. After 12 months of GLM treatment, 80% of RA patients achieved low disease activity (LDA), 37.1% with PsA achieved minimal disease activity and 55.3% with axSpA achieved LDA while persistence at 12 months in all patients was 77.7%. In this 1-year analysis
-
Are systemic corticosteroids effective and safe for treating patients with radicular and non‐radicular low back pain? A Cochrane Review summary with commentary Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-03-04 Nikolaos Barotsis
http://rehabilitation.cochrane.org The aim of this commentary is to discuss the Cochrane Review “Systemic corticosteroids for radicular and non-radicular low back pain”1 by Chou R, Pinto RZ, Fu R, Lowe RA, Henschke N, McAuley JH, and Dana T, published by Cochrane Back and Neck Group. This Cochrane Corner is produced in agreement with the International Journal of Rheumatic Diseases by Cochrane Rehabilitation
-
Association between sacroiliac joint forms and subchondral changes in patients with Crohn's disease Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-28 Oksana Melekh, Felix Barajas Ordonez, Bohdan Melekh, Pablo Rodríguez‐Feria, Maciej Pech, Wiebke Flintrop, Alexey Surov
AimTo assess the relationship between anatomical variants of sacroiliac joint (SIJ) and subchondral changes detected in magnetic resonance enterography (MRE) in patients with Crohn's disease (CD).MethodsThis was a retrospective study of 60 CD patients, who were divided into two groups: with (n = 16) and without SIJ (n = 44) involvement, depending on the presence of inflammatory (bone marrow edema)
-
-
Case report: Autoinflammatory manifestations in a patient with Sjögren's disease Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Hiroyuki Nakamura, Ken Nagahata, Hidenori Amaike, Masatoshi Kanda, Hiroki Takahashi
-
Heterotopic salivary gland tissue Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Qiang Tong, Sheng‐Ming Dai
CONFLICT OF INTEREST STATEMENT We declare no competing interests.
-
Epidemiology and risk factors for cytomegalovirus disease in autoimmune inflammatory rheumatic diseases: A nationwide population‐based study in Taiwan Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Tzu‐Hao Li, Chin‐Fang Su, Chien‐Chih Lai, Yu‐Fan Chang, Fang‐Yi Wu, Yu‐Sheng Chang, Chih‐Cheng Chuang, Chang‐Youh Tsai
-
Long‐term efficacy, safety, and cumulative retention rate of antitumor necrosis factor‐alpha treatment for patients with Behcet's uveitis: A systematic review and meta‐analysis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Xin Guan, Zerui Zhao, Miaomiao Xin, Guangtao Xia, Qingrui Yang, Min Fu
AimThis study aims to evaluate the long‐term efficacy, safety, and cumulative retention rate of antitumor necrosis factor‐alpha (anti‐TNF‐α) therapy for patients with Behcet's uveitis (BU) using meta‐analysis.MethodsWe searched the Web of Science and PubMed databases for eligible studies up to December 1, 2022. The quality of each identified study was assessed using the Joanna Briggs Institute's case
-
Theacrine enhances autophagy and inhibits inflammation via regulating SIRT3/FOXO3a/Parkin pathway Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Jin Li, Wenliang Yan, Hongshan Yuan, Fang Ren
-
An integrated transcriptomics and network pharmacology approach to explore the mechanism of Wang‐Bi tablet against SAPHO syndrome Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-25 Ting Wang, Xun Gong, Congmin Xia, Weijia Kong, Shaohui Geng, Haixu Jiang, Enfan Xiao, Hesong Wang, Yingcai Yu, Chen Li, Kai Yuan
BackgroundSAPHO syndrome is recognized as a rare entity with damage to skin and bones due to inflammation. Currently, the treatment for SAPHO syndrome is still a challenge in clinical practice. In this study, an integrated transcriptomics and network pharmacology approach was applied to explore the therapeutic effect and mechanism of Wang‐Bi tablet (WBT) on SAPHO syndrome.MethodsThe main components
-
Population‐wide long‐term study of incidence, renal failure, and mortality rates for lupus nephritis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-24 Johannes C. Nossent, Helen I. Keen, David B. Preen, Charles A. Inderjeeth
ObjectiveGiven limited regional data, we investigate the state‐wide epidemiology, renal and patient outcomes for lupus nephritis (LN) in Western Australia (WA).MethodsPatients hospitalized with incident SLE (≥2 diagnostic codes in the state‐wide WA Health Hospital Morbidity Data Collection) in the period 1985–2015 were included (n = 1480). LN was defined by the presence of glomerulonephritis and/or
-
Rheumatoid arthritis was causally related to an increased risk of prostate cancer Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-23 Wenjie Li, Ruxue Lv, Wei Wang
-
Hyperuricemia and STOP‐BANG scores in the general population: A cross‐sectional study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-20 In Cheol Hwang, Hong Yup Ahn
-
Application of digital health technology in autoimmune diseases: Opportunity and challenge Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-20 Liang Luo, Chun Li
Digital health technology encompasses a diverse range of innovations, including but not limited to electronic health records, wearable devices, mobile health, telehealth, and artificial intelligence (AI) and machine learning.1 Patients with chronic diseases face increased healthcare utilization expenses, compromised functional capacity, and diminished self-reported health status.2 Chronic conditions
-
The need for precise and accurate imaging navigation in cervical spine surgery for rheumatoid arthritis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-20 Chih‐Wei Huang, Mao‐Shih Lin, Chung‐Yuh Tzeng, Tse‐Yu Chen, Hsi‐Kai Tsou
Rheumatoid arthritis (RA) is the most prevalent inflammatory arthritis, and as many as 88% of RA patients have cervical involvement.1-4 Although advances in medical treatment of RA have decreased the need for late-stage orthopedics or neurosurgery interventions,3, 5 once symptomatic cervical instability occurs, these treatments cannot reverse the progression of the disease, and surgery may be needed
-
Outlook of the jakinibs in systemic lupus erythematous after baricitinib failed Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-20 Chi Chiu Mok
The Janus kinase-signal transducer and activator of transcription (JAK–STAT) is an important intracellular pathway that transduces downstream signals from multiple cytokines, hormones, and hemopoietic growth factors. As these mediators are relevant to the pathophysiology of many immune-mediated conditions,1, 2 antagonizing the JAKs is an attractive therapeutic approach. The jakinibs are small molecules
-
Case report: Lipoprotein (a) related accelerated atherosclerosis in a young patient: An important differential when considering Takayasu arteritis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-20 Georgia Harris, Jason Chuen, Omar Farouque, David L. Hare, Alberta Hoi
CONFLICT OF INTEREST STATEMENT There are no conflict of interests to declare.
-
Frequency of idiopathic intracranial hypertension with ultrasound in patients with fibromyalgia: Relation with function, central sensitization, and neuropathic pain Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-09 Sertaç Ketenci, Bora Uzuner, Dilek Durmuş, Murat Polat
The purpose of this study was to evaluate the prevalence of idiopathic intracranial hypertension (IIH) in fibromyalgia (FMS) patients by utilizing ultrasound to measure the optic nerve sheath diameter (ONSD), a marker of elevated intracranial pressure and also to investigate the relationship with function, fatigue, quality of life (QOL), central sensitization (CS) and neuropathic pain.
-
Case report: Additional use of hydroxychloroquine in treatment-resistant recurrent cerebral infarctions with antiphospholipid antibody syndrome Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-09 Shuntaro Isogai, Masayuki Mizuno, Koji Uehara, Kenji Okita, Taio Naniwa
CONFLICT OF INTEREST STATEMENT TN has received grants and honoraria from Asahi Kasei Pharma. The other authors declare no conflict of interest.
-
FTO overexpression inhibits the invasion and migration of rheumatoid arthritis fibroblast-like synoviocytes by suppressing miR-126-5p Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-06 Yuxia Cai, Ling Wang, Yueling Zheng
-
Hunting uncertainties: JAK inhibitors and cancer risk Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-05 Hsiu-Ming Lee, Huan-Ting Chi, James Cheng-Chung Wei
Janus kinase inhibitors (JAKi) are immunomodulatory medications targeting the JAK-signal transducer and activator of the transcription (JAK–STAT) signaling pathway. Tofacitinib, the initial JAKi, gained approval for treating rheumatoid arthritis (RA) in November 2012.1 Phase III trials indicated that reducing JAK1, JAK2, and JAK3 activity provides viable alternatives with efficacy comparable to injectable
-
Targeting Fli-1 and chemokine axis CXCL10/CXCL13/CXCR3 in systemic lupus erythematosus and lupus nephritis Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-04 Da-Yong Zhu
Fli-1 is a critical factor involved in hematopoietic stem cells, vascular endothelial cells apoptosis, and differentiation. Similarly, Fli-1 regulates immune cell proliferation and differentiation, such as T cells, B cells, and monocytes. Regarding T/B cell dysfunction, SLE including LN is recognized to be associated with abnormal expression and function of Fli-1. Moreover, three ligands of Fli-1 including
-
Meta-analysis reveals that rheumatoid arthritis is associated with worse clinical outcomes among patients with COVID-19 Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-02-04 Guangmin Zhang, Jiane Liu, Jing Wang, Zheng Wang, Jing Zhang, Yu Ding, Xiuming Tang, Wei Wang, Jianxin Liu, Yifei Liu, Jing Liu, Xiaohui Xu
Patients with rheumatoid arthritis (RA) are reported to be more vulnerable to coronavirus disease 2019 (COVID-19), so clinical severity is a particular concern for them. This meta-analysis was performed to evaluate the clinical outcomes in RA patients with COVID-19. A systematic literature search was performed in electronic databases for relevant articles published from January 2020 to October 2022
-
Fusiform swelling of fingers in a young male Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-31 Kannan Karthick, Bains Anupama, Vimal Akhilesh, Elhence Poonam Abhay, Vedant Deepak
CONFLICT OF INTEREST STATEMENT None.
-
Poster Abstracts Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-17
Biphosphonate re-treatment related Atypical Femur Fracture (AFF) N. Abd Rahim1; S. Ahmad Maulana2 1Rheumatology, Hospital Tengku Ampuan Rahimah Klang, Malaysia; 2Rheumatology, Hospital Tengku Ampuan Rahimah Klang, Malaysia Introduction: Biphosphonates have been the gold standard in the management of osteoporosis. It is recommended 3–5 years duration for patients at low-risk of fracture, with a drug
-
Invited Speaker Oral Abstracts Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-17
The homerheum status: Current state of rheumatology workforce in Asia-Pacific J. Consignado Philippine Rheumatology Association While there is a worldwide increase in the prevalence of rheumatic and musculoskeletal diseases (RMDs) with a concordant increase in the demand for and utilization of services, there is a considerable paucity of some cadres of health workers including rheumatologists. This
-
Oral Presentation Abstracts Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-17
Ankylosing spondylitis is associated with increased prevalence of valvular heart diseases: A cross-sectional population-based study WITHDRAWN
-
Author Index Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-17
A Abafita, B. 8 Abbas, H. 341 Abd Rahim, N. 66, 67 Abd, R.A. 376 Abdul Ahmad, S. 68, 69 Abdulgaziz, A. 175 Abe, M. 168 Abe, T. 430, 431 Abeysinghe, D. 181, 181, 182, 230, 396, 397, 397 Abhishek, G.P. 215 Abramova, N. 219 Abu Rahman, A. 68, 69 Achadiono, D. 415 Adam, K. 70, 151, 195, 318, 332, 342, 406 Adeeb, F. 274, 412, 413 Adikaranayake, P. 88 Adil, B. 198 Adita, F. 71, Agafonova, E. 71, 72 Agarwal
-
Thrombocytopenia and disease outcomes in a cohort of patients with systemic lupus erythematosus. A post hoc analysis of the COMOSLE-EGYPT study Int. J. Rheum. Dis. (IF 2.5) Pub Date : 2024-01-10 Sally Samy Mohamed, Sherif Mohamed Gamal, Abir Mokbel, Alkhateeb Kadery Alkamary, Ibrahem Siam, Ahmed Soliman, Fatema Talaat Elgengehy
Thrombocytopenia ranges from 20% to 40% in patients with systemic lupus erythematosus (SLE). It is usually associated with severe disease manifestations and worse disease outcomes.